Alessandro Padovani Selected Research

Cholinesterase Inhibitors (Anticholinesterases)

11/2018	Gender Differences in Neuropsychiatric Symptoms in Mild to Moderate Alzheimer's Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A Post Hoc Analysis of the EVOLUTION Study.
1/2014	Cognitive and affective changes in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational study.
2/2010	Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors.
12/2009	Behavioral dimensions and acetylcholinesterase inhibitor-related effect in Alzheimer disease over time: a latent trajectory modeling.
12/2008	Serum albumin level interferes with the effect of donepezil in Alzheimer's disease.
6/2007	Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's disease.
4/2007	Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.
2/2007	Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study.
6/2005	Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients.
6/2005	Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Padovani Research Topics

Disease

73	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2002
41	Dementia (Dementias) 01/2022 - 01/2002
32	Frontotemporal Dementia (Semantic Dementia) 01/2020 - 09/2005
30	Cognitive Dysfunction 01/2022 - 01/2002
24	Stroke (Strokes) 10/2021 - 03/2002
24	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2018 - 08/2006
20	Ischemic Stroke 01/2022 - 03/2002
17	Parkinson Disease (Parkinson's Disease) 11/2022 - 11/2009
14	Migraine Disorders (Migraine) 01/2022 - 09/2005
13	COVID-19 07/2022 - 01/2020
13	Atrophy 01/2022 - 02/2011
12	Disease Progression 01/2021 - 06/2003
11	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 01/2010
11	Atrial Fibrillation 12/2020 - 01/2012
8	Parkinsonian Disorders (Parkinsonism) 12/2020 - 10/2004
8	Hemorrhage 12/2020 - 08/2010
6	Blood Vessel Dissection 01/2022 - 01/2002
6	Amyloidosis 12/2019 - 12/2016
5	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 09/2019 - 03/2015
5	Headache (Headaches) 01/2019 - 01/2006
5	Primary Progressive Aphasia 01/2016 - 01/2012
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2021 - 01/2016
4	Hypertension (High Blood Pressure) 10/2021 - 02/2004
4	Pain (Aches) 11/2020 - 12/2007
4	Mitochondrial Diseases (Mitochondrial Disease) 10/2018 - 09/2012
4	Ataxia (Dyssynergia) 01/2018 - 12/2007
4	Brain Ischemia (Cerebral Ischemia) 01/2016 - 01/2007
4	Epilepsy (Aura) 05/2013 - 07/2009
3	Inflammation (Inflammations) 11/2022 - 07/2013
3	Encephalitis (Encephalitis, Rasmussen) 11/2022 - 01/2020
3	Leukocytosis (Pleocytosis) 11/2021 - 01/2020
3	Seizures (Absence Seizure) 01/2021 - 07/2009
3	Synucleinopathies 12/2020 - 07/2011
3	Neurologic Manifestations (Neurological Manifestations) 12/2020 - 06/2020
3	Brain Diseases (Brain Disorder) 10/2020 - 04/2014
3	Multiple System Atrophy 01/2020 - 08/2007
3	Cerebral Hemorrhage 01/2020 - 06/2013
3	Hematoma 01/2020 - 08/2010
3	Lewy Body Disease (Lewy Body Dementia) 01/2019 - 10/2004
3	Leukoaraiosis 01/2019 - 08/2010
3	Glycogen Storage Disease (Glycogenosis) 01/2019 - 10/2013
3	Muscular Diseases (Myopathy) 01/2019 - 12/2012
3	Aphasia (Dysphasia) 02/2015 - 10/2011
3	Glioma (Gliomas) 06/2014 - 07/2009
3	Migraine with Aura (Familial Hemiplegic Migraine) 04/2014 - 09/2005
2	Neuroinflammatory Diseases 11/2022 - 10/2020
2	Amyloid Plaque 04/2022 - 08/2010

Drug/Important Bio-Agent (IBA)

40	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2002
31	Amyloid (Amyloid Fibrils)IBA 11/2022 - 01/2002
22	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2002
21	Biological ProductsIBA 01/2022 - 06/2002
15	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2018 - 06/2003
14	GranulinsIBA 01/2017 - 10/2012
13	Apolipoproteins E (ApoE)IBA 01/2022 - 06/2002
10	AnticoagulantsIBA 12/2020 - 02/2014
10	ProgranulinsIBA 01/2018 - 07/2008
7	Cholinergic Agents (Cholinergics)IBA 01/2022 - 01/2012
6	CholesterolIBA 01/2016 - 06/2003
5	SteroidsIBA 05/2022 - 01/2013
5	Pharmaceutical PreparationsIBA 01/2020 - 02/2005
5	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 11/2005
5	EnzymesIBA 01/2019 - 06/2005
5	Serotonin (5 Hydroxytryptamine)IBA 05/2015 - 09/2005
5	ApolipoproteinsIBA 01/2012 - 02/2004
4	SynucleinsIBA 11/2022 - 07/2011
4	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 11/2021 - 04/2007
4	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020 - 04/2007
4	AntibodiesIBA 01/2020 - 09/2007
4	Mitochondrial DNA (mtDNA)IBA 04/2019 - 06/2007
4	salicylhydroxamic acid (SHAM)IBA 01/2019 - 10/2015
4	HomocysteineIBA 02/2012 - 03/2002
4	Donepezil (Aricept)FDA LinkGeneric 12/2008 - 06/2002
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 01/2019
3	Dopamine (Intropin)FDA LinkGeneric 11/2021 - 03/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 01/2017
3	ORALIT (ORS)IBA 10/2021 - 02/2004
3	CytokinesIBA 10/2020 - 06/2011
3	Vitamin K FDA Link 01/2020 - 04/2012
3	DNA (Deoxyribonucleic Acid)IBA 04/2019 - 04/2012
3	GlycogenIBA 01/2019 - 10/2013
3	Thymidine PhosphorylaseIBA 10/2018 - 12/2011
3	Peptides (Polypeptides)IBA 01/2018 - 11/2010
3	LipidsIBA 05/2017 - 06/2009
3	Prothrombin (Factor II)IBA 03/2015 - 03/2005
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2015 - 01/2010
3	Antihypertensive Agents (Antihypertensives)IBA 04/2014 - 06/2005
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 06/2005 - 02/2002
2	Oxygen (Dioxygen)IBA 05/2022 - 05/2021
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 11/2005
2	erenumabIBA 12/2021 - 12/2020
2	Analgesics (Analgesic Drugs)IBA 12/2021 - 01/2006
2	Interleukin-8 (Interleukin 8)IBA 11/2021 - 01/2020
2	InterleukinsIBA 11/2021 - 01/2017

Therapy/Procedure

36	Therapeutics 12/2021 - 06/2003
14	Transcranial Direct Current Stimulation 01/2022 - 10/2011
9	Transcranial Magnetic Stimulation 01/2020 - 10/2011
5	Secondary Prevention 01/2020 - 05/2009
4	Thrombectomy 10/2021 - 03/2017
4	Activities of Daily Living (ADL) 01/2020 - 11/2007
2	Aftercare (After-Treatment) 12/2021 - 11/2021